Abstract
Protein phosphorylation plays a central role in cellular processes. Recently, a considerable interest in the development of inhibitors of protein kinase has been taken. Mitogen activated protein kinases (MAPKs), a group of Ser/Thr protein kinases, are activated by a wide spectrum of extracellular stimuli. Extensive literature reports have indicated the key role of these kinases in inflammatory processes and in immune response. This review outlines relevant aspects on the development of MAPK inhibitors that could form the molecular basis for a new class of anti-inflammatory and immunoregulatory agents. Particular focus is given to their role in regulating the dysfunction of innate immunity. Also, concepts as docking interactions, participation of scaffold proteins in MAPK cascades and its importance in the design of more specific inhibitors are discussed.
Keywords: immune response, mapk, tlr, mapk inhibitor, inflammatory process, cytokine
Current Enzyme Inhibition
Title: Translating MAPK Inhibitors To Anti-Inflammatory Compounds
Volume: 1 Issue: 1
Author(s): C. Ropert
Affiliation:
Keywords: immune response, mapk, tlr, mapk inhibitor, inflammatory process, cytokine
Abstract: Protein phosphorylation plays a central role in cellular processes. Recently, a considerable interest in the development of inhibitors of protein kinase has been taken. Mitogen activated protein kinases (MAPKs), a group of Ser/Thr protein kinases, are activated by a wide spectrum of extracellular stimuli. Extensive literature reports have indicated the key role of these kinases in inflammatory processes and in immune response. This review outlines relevant aspects on the development of MAPK inhibitors that could form the molecular basis for a new class of anti-inflammatory and immunoregulatory agents. Particular focus is given to their role in regulating the dysfunction of innate immunity. Also, concepts as docking interactions, participation of scaffold proteins in MAPK cascades and its importance in the design of more specific inhibitors are discussed.
Export Options
About this article
Cite this article as:
Ropert C., Translating MAPK Inhibitors To Anti-Inflammatory Compounds, Current Enzyme Inhibition 2005; 1 (1) . https://dx.doi.org/10.2174/1573408052952685
DOI https://dx.doi.org/10.2174/1573408052952685 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anticancer Agents Derived from Natural Cinnamic Acids
Anti-Cancer Agents in Medicinal Chemistry Does Metformin Satisfy as an Option for Host-Directed Therapy in COVID-19?
Anti-Infective Agents Exploring Rat Plasmatic Proteomes: What Triggered the Liver Regeneration?
Protein & Peptide Letters New Frontiers in the Therapeutic Management of Transplant Rejection
Current Pharmaceutical Design The Interaction Network of MicroRNAs with Cytokines and Signaling Pathways in Allergic Asthma
MicroRNA Aspects of Antisense Oligodeoxynucleotide, Ribozyme, DNA Enzyme and RNAi Design
Current Medicinal Chemistry - Central Nervous System Agents Systemic Sclerosis: From Pathogenesis Towards Targeted Immunotherapies
Current Rheumatology Reviews Co-opting Functions of Cholinesterases in Neural, Limb and Stem Cell Development
Protein & Peptide Letters Probiotics as Drugs Against Human Gastrointestinal Infections
Recent Patents on Anti-Infective Drug Discovery Pharmacogenomics in Aspirin Intolerance
Current Drug Metabolism Non-Peptidic Small-Molecule Antagonists of the Human Platelet Thrombin Receptor PAR-1
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Phytotherapy and NAFLD - from Goals and Challenges to Clinical Practice
Reviews on Recent Clinical Trials Targeting Aberrant TGF-β Signaling in Pre-Clinical Models of Cancer
Anti-Cancer Agents in Medicinal Chemistry Epigenetic Drugs for Multiple Sclerosis
Current Neuropharmacology Biochanin A Ameliorates Ovalbumin-induced Airway Inflammation through Peroxisome Proliferator-Activated Receptor-Gamma in a Mouse Model
Endocrine, Metabolic & Immune Disorders - Drug Targets Toll-Like Receptors and Myocardial Ischemia/Reperfusion, Inflammation, and Injury
Current Cardiology Reviews Insulin Resistance, Inflammation and Atherosclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Alzheimers Disease, Ceramide, Visfatin and NAD
CNS & Neurological Disorders - Drug Targets CpG Oligodeoxynucleotides: A Novel Therapeutic Approach For Atopic Disorders
Current Drug Targets - Inflammation & Allergy Allogeneic Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia: Current State and Future Directions
Current Stem Cell Research & Therapy